跳至主要内容
临床试验/ACTRN12617000951358
ACTRN12617000951358进行中(未招募)2 期

ymph node grafting for upper limb lymphoedema following breast cancer treatment

Mr Winston McEwan0 个研究点目标入组 65 人开始时间: 2017年7月4日最近更新:

试验速览

阶段
2 期
状态
进行中(未招募)
发起方
入组人数
65

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Female

入选标准

  • 1) Ipsilateral upper limb lymphoedema of severity stage one (but requiring the regular use of a compression garment) or stage two (ISL staging system).
  • 2) Meets definition of lymphoedema: has either a 200 ml inter-limb volume difference, or a 10% difference in limb volume.
  • 3) Previously treated stage 1-3 breast cancer.
  • 4) Undergone local standard lymphoedema therapy for at least three months prior to enrolment and continued participation with techniques.
  • 5) Fit for operative procedure.

排除标准

  • 1) Metastatic breast cancer;
  • 2) Past history of other malignancy with potential lymphatic drainage to either axillae;
  • 3) BMI >40;
  • 4) Current smoker;
  • 5) Congestive heart failure;
  • 6) low serum albumin (<32g/L);
  • 7) Poorly controlled diabetes (bA1c > 70mm/L);
  • 8) Steroid medication;
  • 9) Previous lymph node grafting.

研究者

发起方
Mr Winston McEwan

相似试验

ymph node grafting for breast cancer related... | 临床试验